Roger K. Ferguson

1.5k total citations
71 papers, 1.2k citations indexed

About

Roger K. Ferguson is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Roger K. Ferguson has authored 71 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Cardiology and Cardiovascular Medicine, 19 papers in Molecular Biology and 11 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Roger K. Ferguson's work include Blood Pressure and Hypertension Studies (18 papers), Protein Hydrolysis and Bioactive Peptides (11 papers) and Vitamin K Research Studies (10 papers). Roger K. Ferguson is often cited by papers focused on Blood Pressure and Hypertension Studies (18 papers), Protein Hydrolysis and Bioactive Peptides (11 papers) and Vitamin K Research Studies (10 papers). Roger K. Ferguson collaborates with scholars based in United States, Switzerland and Israel. Roger K. Ferguson's co-authors include Peter H. Vlasses, Heschi H. Rotmensch, Brian N. Swanson, John D. Irvin, Mario L. Rocci, Parviz Mojaverian, M Hichens, C.L. Mitchell, Kanu Chatterjee and Colin Gardner and has published in prestigious journals such as New England Journal of Medicine, JAMA and Annals of Internal Medicine.

In The Last Decade

Roger K. Ferguson

70 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Roger K. Ferguson United States 22 461 282 148 136 128 71 1.2k
B. Waeber Switzerland 21 665 1.4× 327 1.2× 272 1.8× 124 0.9× 91 0.7× 67 1.3k
Thomas Thulin Sweden 21 466 1.0× 451 1.6× 163 1.1× 255 1.9× 68 0.5× 64 1.5k
William B. Abrams United States 18 263 0.6× 265 0.9× 102 0.7× 69 0.5× 96 0.8× 51 926
H. Knauf Germany 20 294 0.6× 449 1.6× 131 0.9× 88 0.6× 67 0.5× 95 1.2k
Thomas E. Gaffney United States 27 626 1.4× 355 1.3× 204 1.4× 195 1.4× 226 1.8× 55 1.9k
W. J. Louis Australia 23 736 1.6× 294 1.0× 195 1.3× 252 1.9× 201 1.6× 54 1.7k
Eva Steiness Denmark 20 478 1.0× 300 1.1× 60 0.4× 102 0.8× 166 1.3× 75 1.3k
Alexander M. M. Shepherd United States 19 424 0.9× 217 0.8× 100 0.7× 128 0.9× 192 1.5× 83 1.7k
LE Ramsay United Kingdom 16 579 1.3× 115 0.4× 287 1.9× 278 2.0× 127 1.0× 53 1.2k
Hiroshi Shionoiri Japan 17 732 1.6× 130 0.5× 331 2.2× 165 1.2× 106 0.8× 94 1.2k

Countries citing papers authored by Roger K. Ferguson

Since Specialization
Citations

This map shows the geographic impact of Roger K. Ferguson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roger K. Ferguson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roger K. Ferguson more than expected).

Fields of papers citing papers by Roger K. Ferguson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roger K. Ferguson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roger K. Ferguson. The network helps show where Roger K. Ferguson may publish in the future.

Co-authorship network of co-authors of Roger K. Ferguson

This figure shows the co-authorship network connecting the top 25 collaborators of Roger K. Ferguson. A scholar is included among the top collaborators of Roger K. Ferguson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roger K. Ferguson. Roger K. Ferguson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rotmensch, Heschi H., et al.. (1993). Comparisons of Beta‐Adrenergic Blocking Properties of S‐ and R‐Timolol in Humans. The Journal of Clinical Pharmacology. 33(6). 544–548. 1 indexed citations
2.
Ujhelyi, Michael R., Roger K. Ferguson, & Peter H. Vlasses. (1989). Angiotensin‐Converting Enzyme Inhibitors: Mechanistic Controversies. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 9(6). 351–362. 22 indexed citations
3.
Pixley, John S., et al.. (1989). Comparison of Once‐Daily Captopril or Enalapril in Mild Essential Hypertension. The Journal of Clinical Pharmacology. 29(2). 118–122. 5 indexed citations
4.
Rotmensch, Heschi H., Peter H. Vlasses, & Roger K. Ferguson. (1988). Angiotensin-Converting Enzyme Inhibitors. Medical Clinics of North America. 72(2). 399–425. 40 indexed citations
5.
Conner, Dale P., et al.. (1987). Hemodynamic Effects During Rest and Exercise of Bucindolol in Hypertensive Men. The Journal of Clinical Pharmacology. 27(4). 300–303. 2 indexed citations
6.
Vlasses, Peter H., Roger K. Ferguson, Mario L. Rocci, et al.. (1986). Lethal Accumulation of Procainamide Metabolite in Severe Renal Insufficiency. American Journal of Nephrology. 6(2). 112–116. 10 indexed citations
7.
Vlasses, Peter H., Dale P. Conner, Heschi H. Rotmensch, et al.. (1986). Double-blind comparison of captopril and enalapril in mild to moderate hypertension. Journal of the American College of Cardiology. 7(3). 651–660. 15 indexed citations
8.
Fruncillo, Richard J., et al.. (1986). Effect of Renal Failure or Biliary Stasis on the Pharmacokinetics of Amiodarone in the Rat. Journal of Pharmaceutical Sciences. 75(2). 150–154. 9 indexed citations
9.
Vlasses, Peter H., Lair G.T. Ribeiro, Heschi H. Rotmensch, et al.. (1985). Initial Evaluation of Transdermal Timolol. Journal of Cardiovascular Pharmacology. 7(2). 245–250. 39 indexed citations
10.
Rotmensch, Heschi H., Peter H. Vlasses, Brian N. Swanson, et al.. (1984). Antihypertensive efficacy of once daily MK-521, a new nonsulfhydryl angiotensin-converting enzyme inhibitor. The American Journal of Cardiology. 53(1). 116–119. 26 indexed citations
11.
Ferguson, Roger K., et al.. (1984). Lidocaine Removal During Resin Hemoperfusion for Phenobarbital Intoxication. Artificial Organs. 8(2). 229–231. 2 indexed citations
12.
Ferguson, Roger K., Peter H. Vlasses, & Heschi H. Rotmensch. (1984). Clinical applications of angiotensin-converting enzyme inhibitors. The American Journal of Medicine. 77(4). 690–698. 33 indexed citations
13.
Vlasses, Peter H., et al.. (1983). Comparative Antihypertensive Effects of Enalapril Maleate and Hydrochlorothiazide, Alone and in Combination. The Journal of Clinical Pharmacology. 23(5-6). 227–233. 27 indexed citations
14.
Vlasses, Peter H., et al.. (1983). Disposition of Intravenous and Intraperitoneal Cefoxitin During Chronic Intermittent Peritoneal Dialysis. American Journal of Kidney Diseases. 3(1). 67–70. 1 indexed citations
15.
Ferguson, Roger K., et al.. (1983). Effect of captopril and propranolol, alone and in combination, on the responses to isometric and dynamic exercise in normotensive and hypertensive men.. PubMed. 3(2 Pt 1). 125–30. 6 indexed citations
16.
Swanson, Brian N., et al.. (1982). Sulindac disposition when given once and twice daily. Clinical Pharmacology & Therapeutics. 32(3). 397–403. 28 indexed citations
17.
Ferguson, Roger K. & Peter H. Vlasses. (1981). Clinical pharmacology and therapeutic applications of the new oral angiotensin converting enzyme inhibitor, captopril. American Heart Journal. 101(5). 650–656. 44 indexed citations
18.
Jaeger, Philippe, et al.. (1978). Mechanism of blood pressure reduction by teprotide (SQ 20881) in rats. Kidney International. 13(4). 289–296. 24 indexed citations
19.
Brunk, S. Fred, et al.. (1973). A Teaching Format in Clinical Pharmacology. Comparison of Two Xanthines and a Placebo. PubMed. 13(4). 121–126. 8 indexed citations
20.
Ferguson, Roger K., William J. Adams, & C.L. Mitchell. (1969). Studies of tolerance development to morphine analgesia in rats tested on the hot plate. European Journal of Pharmacology. 8(1). 83–92. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by B. Waeber Breakdown of academic impact, for papers by Thomas Thulin Breakdown of academic impact, for papers by William B. Abrams Breakdown of academic impact, for papers by H. Knauf Breakdown of academic impact, for papers by Thomas E. Gaffney Breakdown of academic impact, for papers by W. J. Louis Breakdown of academic impact, for papers by Eva Steiness Breakdown of academic impact, for papers by Alexander M. M. Shepherd Breakdown of academic impact, for papers by LE Ramsay Breakdown of academic impact, for papers by Hiroshi Shionoiri
Rankless by CCL
2026